跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEVETEN PLUS 600/12.5 eprosartan 600mg/hydrochlorothiazide 12.5mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
TEVETEN PLUS 600/12.5 eprosartan 600mg/hydrochlorothiazide 12.5mg tablet blister pack
Approved
STANDARD
TEVETEN PLUS 600/12.5 eprosartan 600mg/hydrochlorothiazide 12.5mg tablet blister pack
Viatris Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
faac12006fac1420
Company
Viatris Pty Ltd
Type
Standard
Approval Details
Approval Id
faac12006fac1420
Product Name
TEVETEN PLUS 600/12.5 eprosartan 600mg/hydrochlorothiazide 12.5mg tablet blister pack
Artg Id
143172
Artg Name
TEVETEN PLUS 600/12.5 eprosartan 600mg/hydrochlorothiazide 12.5mg tablet blister pack
Sponsor
Viatris Pty Ltd
Company Detail Path
/organization/viatris-pty-ltd
Artg Date
2007-08-20
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/b12697133ba8e97c4acc06665e385a4f.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/7cae9947860933135036f0834b37dad0.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
faac12006fac1420
Type
Standard
Back to TGA Approvals